A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0843
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer ; volume:67 ; number:4 ; day:3 ; month:6 ; year:2010 ; pages:751-764 ; date:4.2011
Cancer chemotherapy and pharmacology ; 67, Heft 4 (3.6.2010), 751-764, 4.2011
- Creator
-
Tolcher, Anthony W.
Appleman, Leonard J.
Shapiro, Geoffrey I.
Mita, Alain C.
Cihon, Frank
Mazzu, Arthur
Sundaresan, Pavur R.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00280-010-1372-3
- URN
-
urn:nbn:de:101:1-2019111703261883770064
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tolcher, Anthony W.
- Appleman, Leonard J.
- Shapiro, Geoffrey I.
- Mita, Alain C.
- Cihon, Frank
- Mazzu, Arthur
- Sundaresan, Pavur R.
- SpringerLink (Online service)
Other Objects (12)
HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma
Atezolizumab plus Bevacizumab versus Sorafenib in the Chinese Subpopulation with Unresectable Hepatocellular Carcinoma: Phase 3 Randomized, Open-Label IMbrave150 Study
An open-label, flexible dose adaptive study evaluating the efficacy of vortioxetine in subjects with panic disorder
PHOCUS: A Phase 3, Randomized, Open-Label Study of Sequential Treatment with Pexa-Vec (JX-594) and Sorafenib in Patients with Advanced Hepatocellular Carcinoma
Cardiovascular events by different target hemoglobin levels in ESA-hyporesponsive hemodialysis patients: a multicenter, open-label, randomized controlled study
IGF-1 in autosomal dominant cerebellar ataxia - open-label trial
Effects of practicing yoga on alexisomia: an open-label trial
A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis
Safety of Rimegepant in Adults with Migraine and Cardiovascular Risk Factors: Analysis of a Multicenter, Long-Term, Open-Label Study
An open-label feasibility trial of transdermal cannabidiol for hand osteoarthritis
Managing pasireotide-associated hyperglycemia: a randomized, open-label, Phase IV study
Open-label placebos for menopausal hot flushes: a randomized controlled trial
HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma
Atezolizumab plus Bevacizumab versus Sorafenib in the Chinese Subpopulation with Unresectable Hepatocellular Carcinoma: Phase 3 Randomized, Open-Label IMbrave150 Study
An open-label, flexible dose adaptive study evaluating the efficacy of vortioxetine in subjects with panic disorder
PHOCUS: A Phase 3, Randomized, Open-Label Study of Sequential Treatment with Pexa-Vec (JX-594) and Sorafenib in Patients with Advanced Hepatocellular Carcinoma
Cardiovascular events by different target hemoglobin levels in ESA-hyporesponsive hemodialysis patients: a multicenter, open-label, randomized controlled study
IGF-1 in autosomal dominant cerebellar ataxia - open-label trial
Effects of practicing yoga on alexisomia: an open-label trial
A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis
Safety of Rimegepant in Adults with Migraine and Cardiovascular Risk Factors: Analysis of a Multicenter, Long-Term, Open-Label Study
An open-label feasibility trial of transdermal cannabidiol for hand osteoarthritis
Managing pasireotide-associated hyperglycemia: a randomized, open-label, Phase IV study
Open-label placebos for menopausal hot flushes: a randomized controlled trial
HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma
Atezolizumab plus Bevacizumab versus Sorafenib in the Chinese Subpopulation with Unresectable Hepatocellular Carcinoma: Phase 3 Randomized, Open-Label IMbrave150 Study
An open-label, flexible dose adaptive study evaluating the efficacy of vortioxetine in subjects with panic disorder
PHOCUS: A Phase 3, Randomized, Open-Label Study of Sequential Treatment with Pexa-Vec (JX-594) and Sorafenib in Patients with Advanced Hepatocellular Carcinoma
Cardiovascular events by different target hemoglobin levels in ESA-hyporesponsive hemodialysis patients: a multicenter, open-label, randomized controlled study
IGF-1 in autosomal dominant cerebellar ataxia - open-label trial
Effects of practicing yoga on alexisomia: an open-label trial
A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis
Safety of Rimegepant in Adults with Migraine and Cardiovascular Risk Factors: Analysis of a Multicenter, Long-Term, Open-Label Study
An open-label feasibility trial of transdermal cannabidiol for hand osteoarthritis
Managing pasireotide-associated hyperglycemia: a randomized, open-label, Phase IV study